000			01553cam a22004094a 4500
005			20150623164336.0
008			001222s2001 gw a b 001 0 eng
010			_a 00054930
020			_a3540415033 (alk. paper)
035			_a(DNLM)101083644
040			_aDNLM/DLC _cDLC _dDLC
042			_apcc
060	1	0	_aWG 370 _bRP
082	0	0	_a616.12061 _221
084			_a616.12061 _bRP
100	1		_aRydén,L.E.
245	1	0	_aPrevention of disease progression throughout the cardiovascular continuum _h[[Book] :] _bthe role of adrenergic -blockade / _cL.E. Rydén (ed.).
260			_aBerlin ; _aNew York : _bSpringer, _cc2001.
300			_avi, 147 p. : _bcol. ill. ; _c25 cm..
504			_aIncludes bibliographical references and index.
650		0	_aHeart _xDiseases _xChemotherapy.
650		0	_aSympatholytic agents.
650		0	_aHeart failure _xChemotherapy.
650	1	2	_aHeart Failure, Congestive _xprevention & control.
650	2	2	_aAdrenergic Antagonists _xtherapeutic use.
650	2	2	_aHeart Failure, Congestive _xdrug therapy.
650	2	2	_aHypertension _xdrug therapy.
650	2	2	_aHypertrophy, Left Ventricular _xdrug therapy.
700	1		_aRydén, Lars E.
906			_a7 _bcbc _corignew _d1 _eocip _f20 _gy-gencatlg
925	0		_aacquire _b1 shelf copy _xpolicy default
955			_ato NLM pc17 12-22-00; yb23 to ASCD 12-28-00; jc02 to technician 01-03-01; jc03 to Dewey 01-03-01;aa03 1-10-01; CIP ver. pv04 04-19-01 to BCCD
955			_ata15 2001-07-09 DEOF fixed
001			0000070408
003			0000
942			_cBK
999			_c12911 _d12911